A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia

References

• Bodnar LM, Cogswell ME, McDonald T. Have we forgotten the significance of postpartum iron deficiency?. Am J Obstet Gynecol. 2005; 193: 36–44
   PubMed Web of Science ®Google Scholar
• Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, et al. Maternal iron deficiency anaemia affects postpartum emotions and cognitions. J Nutr. 2005; 135: 267–72
   PubMed Web of Science ®Google Scholar
• Corwin EJ, Murray-Kolb LE, Beard JL. Low hemoglobin level is a risk factor for post partum depression. J Nutr. 2003; 133: 4139–42
   PubMed Web of Science ®Google Scholar
• Agarwal R. Nonhematological benefits of iron. Am J Nephrol. 2007; 27: 565–71
   PubMed Web of Science ®Google Scholar
• Wulff M, Ekström E-C. Iron supplementation during pregnancy in Sweden: to what extent is the national recommendation followed?. Acta Obstet Gynecol Scand. 2003; 82: 628–35
   PubMed Web of Science ®Google Scholar
• Milman N, Agger OA, Nielsen OJ. Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish Women. Dan Med Bull. 1991; 38: 471–6
   PubMed Web of Science ®Google Scholar
• Zimmermann R, Breymann C, Richter C, Huch R, Huch A. rhEPO treatment of postpartum anaemia. J Perinat Med. 1995; 23: 111–7
   PubMed Web of Science ®Google Scholar
• Lebrecht A, Aberlin F, Eberhard J. Anaemia in puerperium; parenteral iron substitution renders erythropoietin therapy dispensable. Geburtshilfe Frauenheilkd. 1995; 55: 167–70
   PubMedGoogle Scholar
• Wågström E, Akesson A, Van Rooijen M, Larson B, Bremme K. Erthropoietin and intravenous iron therapy in postpartum anaemia. Acta Obstet Gynecol Scand. 2007; 86: 957–62
   PubMed Web of Science ®Google Scholar
• Bhandal N, Russel R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG. 2006; 113: 1248–52
   PubMed Web of Science ®Google Scholar
• Ware JE, Gandek B, IQOLA Project Group. The SF-36 Health Survey: development and use in mental health research and the IQOLA project. Int J Ment Health. 1994;23:49–73.
   Web of Science ®Google Scholar
• Chalder T, Berelowitz G, Pawlikowksa T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993; 37: 147–53
   PubMed Web of Science ®Google Scholar
• Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 health survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol. 1998; 51: 1069–76
   PubMed Web of Science ®Google Scholar
• Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998; 45: 53–65
   PubMed Web of Science ®Google Scholar
• Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974; 15: 443–53
   PubMed Web of Science ®Google Scholar
• Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trials. Biometrics. 1975; 31: 103–15
   PubMed Web of Science ®Google Scholar
• McEntegart DJ. The pursuit of balance using stratified and dynamic randomization techniques: an overview. Drug Information Journal. 2003; 37: 293–309
   Web of Science ®Google Scholar
• Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol. 2007; 110: 267–78
   PubMed Web of Science ®Google Scholar
• Kaushansky K, Kipps TJ. Hematopoetic agents. Goodman and Gilman's the pharmacological basis of therapeutics11th ed, LL Brunton, JS Lazo, KL Parker. McGraw-Hill Companies, New York 2006; 1433–65
   Google Scholar
• Kääpä P, Koistinen E. Maternal and neonatal C-reactive protein after interventions during delivery. Acta Obstet Gynecol Scand. 1993; 72: 543–6
   PubMed Web of Science ®Google Scholar
• Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. The Lancet. 2007; 369: 1502–4
   PubMed Web of Science ®Google Scholar
• Jansen AJ, Duvekot JJ, Hop WC, Essink-Bot ML, Beckers EA, Karsdorp VH, et al. New insights into fatigue and health-related quality of life after delivery. Acta Obstet Gynecol Scand. 2007; 86: 579–84
   PubMed Web of Science ®Google Scholar
• Tam KF. Mild postnatal anaemia: is it a problem?. Am J Perinatol. 2005; 22: 345–9
   PubMed Web of Science ®Google Scholar
• Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, et al. Iron-supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ 2003; 326: 1124–6
   PubMed Web of Science ®Google Scholar
• Bailie GR, Clark JA, Lane CE, Lane PL. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant. 2005; 20: 1443–9
   PubMed Web of Science ®Google Scholar
• Flesland O. A comparison of complication rates bases on published haemovigilance data. Intensive Care Med. 2007; 33: S17–S21
   PubMedGoogle Scholar
• Glenngård AH, Persson U, Söderman C. Costs associated with blood transfusions in Sweden – the societal cost of autologous, allogenic and perioperative RBC transfusion. Transfus Med. 2005; 15: 295–306
   PubMed Web of Science ®Google Scholar
• Ekeroma AJ, Ansari A, Stirrat GM. Blood transfusion in obstetrics and gynaecology. Br J Obstet Gynaecol. 1997; 104: 278–84
   PubMedGoogle Scholar
• Broche D.-E., Gay C, Armand-Branger S, Grangeasse L, Terzibachian J.-J. Severe anaemia in the immediate post-partum period clinical practice and value of intravenous iron. Gynecol Obstet Fertil. 2004; 32: 613–9
   PubMedGoogle Scholar
• Kotto-Kome AC, Calhoun DA, Montenegro R, Sosa R, Maldonado L, Christensen RD. Effect of administering recombinant e rythropoietin to women with postpartum anemia: a meta-analysis. J Perinatal. 2004; 24: 11–5
   PubMedGoogle Scholar